Elevated IL-37 levels in the plasma of patients with severe coronary artery calcification
-
Meng CHAI,
-
Hai-Tao ZHANG,
-
Yu-Jie ZHOU,
-
Qing-Wei JI,
-
Qing YANG,
-
Yu-Yang LIU,
-
Ying-Xin ZHAO,
-
Dong-Mei SHI,
-
Wei LIU,
-
Li-Xia YANG,
-
Lin-Lin ZHANG,
-
Jing LIANG
-
-
Abstract
Background Coronary artery calcification (CAC) is a predictor of cardiovascular events and plaque burden and is closely associated with chronic inflammation. Interleukin (IL)-37 is a newly discovered member of the IL-1 family and is considered an anti-inflammatory cytokine. Our recent study on mice indicated that IL-37 could attenuate atherosclerosis and vascular calcification, which suggests that IL-37 could be associated with the development of atherosclerosis and related diseases. The aim of this study was to investigate if IL-37 plays a role in the progression of CAC in patients. Methods Two hundred participants with suspected cardiovascular disease were recruited. The levels of plasma IL-37, osteoprotegerin (OPG), hypersensitive C-reactive protein (hsCRP) together with other biochemical parameters were measured, and a coronary calcium assessment was carried out by multi-detector row CT. A score of 400 AU denotes severe CAC. Results Our initial data showed that there were no apparent differences in plasma IL-37 levels among patients with or without mild or moderate CAC. However, IL-37 levels were significantly increased in patients with severe CAC (P r = 0.360, P Conclusions This study demonstrates that the anti-inflammatory cytokine IL-37 is associated with high coronary calcium levels, suggesting that IL-37 expression may be caused by the activation of inflammation and that IL-37 might become a predictor of severe CAC in the future, which requires further investigation.
-
-